Navigation Links
Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Date:11/1/2010

Center at Cedars-Sinai Medical Center in Los Angeles, and one of the investigators for the study.  "The initial results of ABT-450/r in patients with HCV suggest that ABT-450/r has favorable potency in the most common HCV genotype and that ABT-450/r could be an important element in a combination direct-acting antiviral regimen for treatment of HCV."

"Abbott has focused its antiviral research expertise on finding new treatment options for HCV-infected patients that could transform current therapy – by shortening the duration of treatment and increasing cure rates," said Scott Brun, M.D., divisional vice president, infectious disease development, Abbott.  "We continue to explore the potential for use of ABT-450/r in a variety of combination regimens."

"We are very encouraged by the 3-day monotherapy and 4-week rapid virologic response results for ABT-450 and we look forward to further clinical results from the program," said Jay Luly, Ph.D, president and chief executive officer, Enanta Pharmaceuticals.  "This data is an important step in our HCV program, and for advancing our broader vision to improve patient care in this field."

Study Objectives and DesignThe objectives of the 48-week Phase 2 study are to assess the safety, tolerability, pharmacokinetics, and antiviral activity of multiple dose strengths of ABT-450/r in treatment-naïve adults infected with HCV genotype 1, which is the most common and difficult to treat form of the infection in the developed world.  Trial endpoints include early virologic response and rapid virologic response.  Initial antiviral activity was evaluated via a 3-day treatment period during which ABT-450/r was administered alone. Subsequently, ABT-450/r was administered with pegIFN/RBV (SOC) for 12 weeks, followed by treatment with SOC alone for an additional 36 weeks.  Participants are then monitored post therapy for 24 weeks for sustained virologic response.

ABT-4
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Abbott Again Recognized for Environmental Initiatives in Illinois
2. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
3. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
6. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
7. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
8. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
9. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
10. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
11. Abbott Declares 347th Consecutive Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014  Mark Farrah Associates ... providing a summary of the 2015 marketplace exchange ... trends.  According to a recent ... and Evaluation, Department of Health and Human Services) ... in individual medical plans through the Marketplace as ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, announced today ... dosed in a pharmacokinetic and pharmacodynamic study with ... neuropathic pain. Racemic methadone is a ... pain states and substitution therapy in opioid addiction.  ...
(Date:12/19/2014)... LONDON , December 19, 2014 ... authentication services in the World announced the appointment of ... Anthony R. Vonsée, as Chief Channels and Partner Officer. ... Datanomic since 2004 through to its acquisition by Oracle ... Development Director at Geneva and ...
Breaking Medicine Technology:Insights into the Marketplace and Individual Market Growth 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Aegate Appoints new CTO and Chief Channels & Partner Officer 2Aegate Appoints new CTO and Chief Channels & Partner Officer 3Aegate Appoints new CTO and Chief Channels & Partner Officer 4
... UPI ) announced today that it will release financial ... 30, 2011, at the market close on Thursday, July 28, ... these results on Thursday, July 28, 2011 at 4:30 p.m. ... Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial ...
... PAREXEL International Corporation (NASDAQ: ... today that it has achieved a significant milestone by ... to help biopharmaceutical companies accelerate development for the Asia/Pacific ... study —an approach to determine safety and tolerability, as ...
Cached Medicine Technology:Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011 2PAREXEL Achieves 100th Asian Ethnobridging Study Milestone 2PAREXEL Achieves 100th Asian Ethnobridging Study Milestone 3PAREXEL Achieves 100th Asian Ethnobridging Study Milestone 4PAREXEL Achieves 100th Asian Ethnobridging Study Milestone 5
(Date:12/24/2014)... For nearly 20 years, June Cotner has been the ... of life's rites of passage. Here, she joins forces ... Toasts: The Perfect Words to Celebrate Every Occasion ... category and containing many original toasts written just for ... tome contains sayings famous and profound, suitable and sentimental. ...
(Date:12/24/2014)... December 24, 2014 As 2014 draws ... homeowners that before investing time and money into a ... licensed professional that specializes in tankless and eco-friendly products ... replace their water heater in 2015 to research “green” ... , Greenstar Home Services specializes in eco-friendly ...
(Date:12/24/2014)... Doheny HealthDay Reporter TUESDAY, ... fast food might hurt your child in the classroom, a ... in fifth grade lagged behind by eighth grade, said researchers ... U.S. students. "The largest effects were found for the ... leader Kelly Purtell, assistant professor of human sciences at Ohio ...
(Date:12/24/2014)... Dec. 23, 2014 (HealthDay News) -- Long-term fear of terrorists ... early death, a new study from Israel suggests. , , ... study involved 17,300 Israelis. In Israel, the threat of war ... than 60 years. "We wanted to test whether fear ... increased risk of death," study author Hermona Soreq, a professor ...
(Date:12/22/2014)... Kan. (PRWEB) December 22, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Tri-City Medical Center in Oceanside, Calif. The ... industry, B. E. Smith has recently placed more than ... Center is a community owned, 397-bed, Gold Seal-approved, full-service ...
Breaking Medicine News(10 mins):Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:Can Fast Food Hinder Learning in Kids? 2Health News:Terrorism Fears May Shorten Your Life, Study Finds 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 2Health News:Tri-City Medical Center Retains B. E. Smith to Recruit New Chief Compliance Officer 3
... Addiction and Mental Health (CAMH) and researchers in Germany ... for acetaldehyde-related cancer. Heavy drinkers may be at ... Acetaldehyde is ubiquitous in daily life in Ontario. ... the air and tobacco smoke, ingested from alcohol and ...
... "The Road Ahead and How to Navigate It" ... in the current enforcement and economic environments MINNEAPOLIS, ... critical to all health care providers related to ... contained in President Obama,s Stimulus Bill is one ...
... Savings on both Contact Lenses and Youth EyewearBENTONVILLE, Ark., ... out-of-pocket health care costs, Wal-Mart Stores Inc. today announced ... contact lenses* and youth eyewear. In an effort to ... CONTACTS, the world,s largest retailer of contact lenses, are ...
... from local business, labor, academic and health care ... Maryland House of Delegates Health & Government Operations ... Maryland -- a unique network of partners dedicated ... in the United States and in Maryland. "New ...
... consecutive year, Blue Cross and Blue Shield of Florida, ... Companies for Diversity. BCBSF is ranked 32nd on the ... http://www.newscom.com/cgi-bin/prnh/20000427/BLUELOGOA )Many factors led to BCBSF,s successes in its ... , The ...
... equivalent doses, automatic drug updates -SAN DIEGO, March ... wireless, handheld barcode point-of-care (BPOC) solutions ... information about its industry-leading NDC matching capability at ... in booth 1476.The new NDC matching capability, released ...
Cached Medicine News:Health News:Acetaldehyde in alcohol -- no longer just the chemical that causes a hangover 2Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 2Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 3Health News:HIPAA Amendments Contained in President Obama's Stimulus Bill Among New Sessions Added to HCCA's 2009 Compliance Institute 4Health News:Walmart Makes Eye Care More Affordable for Millions of Americans 2Health News:Walmart Makes Eye Care More Affordable for Millions of Americans 3Health News:Walmart Makes Eye Care More Affordable for Millions of Americans 4Health News:Maryland 'We Work for Health' Calls on Elected Officials to Focus on Medical Research and Innovation to Bolster Economy and Find Cures 2Health News:Maryland 'We Work for Health' Calls on Elected Officials to Focus on Medical Research and Innovation to Bolster Economy and Find Cures 3Health News:Blue Cross and Blue Shield of Florida in DiversityInc's Top 50 Companies for Diversity for Seventh Consecutive Year 2Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 2Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 3Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 4Health News:IntelliDOT to Showcase New NDC Matching Capability at HIMSS 2009 5
Sealing tape featuring 3M adhesive technology. Superior optical properties. Low autofluorescense. Some residue will remain if using DMSO. Non-tacky to skin and gloves....
Sealing tape featuring 3M adhesive technology. Repeat piercing with minimal residue. Not recommended for DMSO. Non-tacky to skin and gloves....
Sealing tape, white Rayon, breathable, NS...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Medicine Products: